Consensus Cloud Solutions Announces Pricing Of Secondary Offering Of 500K Shares Held By Ziff Davis
September 14, 4:48 PM
Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) (the "Company" or "Consensus") announced today the pricing of an underwritten offering of 500,000 shares of its common stock currently owned by Ziff
Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise
September 14, 10:27 AM
POINT Biopharma Global Inc (NASDAQ:PNT) priced its public offering of 13.9 million shares at $9.00 per share, with gross proceeds…
After One Year Of Regulatory Hold, Larimar’s Ataxia Candidate Sees Some Hope
September 14, 9:35 AM
The FDA has cleared the initiation of Larimar Therapeutics Inc’s (NASDAQ:LRMR) 25 mg cohort of Phase 2 trial of CTI-1601 in Friedreich’s…
Psychedelics Companies Are Teaming Up To Offer Access Veterans
September 13, 8:16 PM
Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on access needs for veterans.
Edgewise Therapeutics Announces Proposed $100M Offering Of Common Stock
September 13, 8:49 AM
BOULDER, Colo.--(BUSINESS WIRE)-- Edgewise Therapeutics, Inc., (NASDAQ:EWTX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering of $100 million of its common
Codiak BioSciences Priced ~13.33M Share Offering Plus Accompanying Warrants at Combined Price of $1.50/Share Plus Warrant
September 13, 4:51 AM
Codiak BioSciences, Inc.
Relay Therapeutics Priced ~11.32M Share Public Offering of Common Stock @$26.50/Share
September 13, 4:49 AM
Relay Therapeutics, Inc. (Nasdaq: RLAY) announcedthe pricing of an underwritten public offering of 11,320,755 shares of its common stock at a public offering price of $26.50 per share. Relay Therapeutics also granted the underwriters a 30-day option to purchase up to an additional 1,698,113 shares of its common stock.
Revance Therapeutics Priced Upsized 8M Sharw Public Offering of Common Stock @$25/Share
September 13, 4:47 AM
Revance Therapeutics, Inc. (Nasdaq: RVNC) announced the pricing of an upsized underwritten public offering of 8,000,000 shares of its common stock. The shares of common stock are being offered at a public offering price of $25.00 per share. All of the shares are being offered by Revance.
Crestwood Announces Pricing of Secondary Offering of 11.4M Common Units for Gross Proceeds of $306.7M
September 13, 4:44 AM
Crestwood Equity Partners LP (NYSE: CEQP) announced the pricing of the previously announced underwritten secondary offering by certain subsidiaries of Chord Energy Corporation (NASDAQ: CHRD) (f/k/a Oasis Petroleum Inc.) (the "Selling Unitholders") of an aggr